Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells
- PMID: 9707621
- PMCID: PMC21482
- DOI: 10.1073/pnas.95.17.10182
Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells
Abstract
Retroviral vectors based on the Moloney murine leukemia virus (MoMuLV) have shown inconsistent levels and duration of expression as well as a propensity for the acquisition of de novo methylation in vivo. MoMuLV-based vectors are known to contain sequences that are capable of suppressing or preventing expression from the long terminal repeat. Previously, we constructed a series of modified retroviral vectors and showed that they function significantly better than MoMuLV-based vectors in vitro. To test the efficacy of the modified vectors in hematopoietic stem cells in vivo, we examined gene expression and proviral methylation in differentiated hematopoietic colonies formed in the spleens of mice after serial transplantation with transduced bone marrow (2 degreesCFU-S). We found a significant increase in the frequency of expression with our modified vectors (>90% expression in vector DNA containing 2 degreesCFU-S) over the frequency observed with the standard MoMuLV-based vector (28% expression in vector containing 2 degreesCFU-S). Expression from the modified vectors was highly consistent, with expression in >50% of the vector-containing 2 degreesCFU-S from all 20 transplant recipients analyzed, whereas expression from the standard MoMuLV-based vector was inconsistent, with expression in 0-10% of the vector containing 2 degreesCFU-S from 8 recipients and expression in >50% of the vector-containing 2 degreesCFU-S from 4 other recipients. In addition, we established that the modified vectors had a lower level of DNA methylation than the control vector. These findings represent significant advances in the development and evaluation of effective retroviral vectors for application in vivo.
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/21482/bin/pq1681281001.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/21482/bin/pq1681281002.gif)
![Figure 3](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/21482/bin/pq1681281003.gif)
![Figure 4](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/21482/bin/pq1681281004.gif)
![Figure 5](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/21482/bin/pq1681281005.gif)
Similar articles
-
Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo.Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2567-71. doi: 10.1073/pnas.91.7.2567. Proc Natl Acad Sci U S A. 1994. PMID: 8146155 Free PMC article.
-
Improved expression in hematopoietic and lymphoid cells in mice after transplantation of bone marrow transduced with a modified retroviral vector.Blood. 1999 Nov 15;94(10):3349-57. Blood. 1999. PMID: 10552944 Free PMC article.
-
Retroviral vector design for long-term expression in murine hematopoietic cells in vivo.Blood. 1994 Sep 15;84(6):1812-22. Blood. 1994. PMID: 8080986
-
Improved retroviral vectors for hematopoietic stem cell protection and in vivo selection.J Hematother. 1996 Aug;5(4):323-9. doi: 10.1089/scd.1.1996.5.323. J Hematother. 1996. PMID: 8877707 Review.
-
Retroviral-mediated gene transfer into mammalian cells.Blood Cells. 1987;13(1-2):285-98. Blood Cells. 1987. PMID: 3311223 Review.
Cited by
-
Tagged IDS causes efficient and engraftment-independent prevention of brain pathology during lentiviral gene therapy for Mucopolysaccharidosis type II.Mol Ther Methods Clin Dev. 2023 Nov 2;31:101149. doi: 10.1016/j.omtm.2023.101149. eCollection 2023 Dec 14. Mol Ther Methods Clin Dev. 2023. PMID: 38033460 Free PMC article.
-
Heterozygous variants of CLPB are a cause of severe congenital neutropenia.Blood. 2022 Feb 3;139(5):779-791. doi: 10.1182/blood.2021010762. Blood. 2022. PMID: 34115842 Free PMC article.
-
Promoter usage regulating the surface density of CAR molecules may modulate the kinetics of CAR-T cells in vivo.Mol Ther Methods Clin Dev. 2021 Mar 13;21:237-246. doi: 10.1016/j.omtm.2021.03.007. eCollection 2021 Jun 11. Mol Ther Methods Clin Dev. 2021. PMID: 33869653 Free PMC article.
-
Aberrant Clonal Hematopoiesis following Lentiviral Vector Transduction of HSPCs in a Rhesus Macaque.Mol Ther. 2019 Jun 5;27(6):1074-1086. doi: 10.1016/j.ymthe.2019.04.003. Epub 2019 Apr 9. Mol Ther. 2019. PMID: 31023523 Free PMC article.
-
Cytoreductive conditioning intensity predicts clonal diversity in ADA-SCID retroviral gene therapy patients.Blood. 2017 May 11;129(19):2624-2635. doi: 10.1182/blood-2016-12-756734. Epub 2017 Mar 28. Blood. 2017. PMID: 28351939 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical